Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...

About This EventVir Biotechnology (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious ...

Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price ...

China-based Xiamen Kang Zhongyuan Biotechnology recalled certain cough drops in the U.S. in connection with Food and Drug Administration observations during a manufacturing-facility inspection "that ...

EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T-cell engagers, is pleased to announce that the ...

In a major boost to Nigeria’s capacity to tackle climate change and food insecurity, the JR Biotek Foundation, Mastercard Foundatio, and the University of Cambridge have partnered the Michael Okpara ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16 ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company advancing cancer treatments, announced ...

Showbox releases the first trailer for 'Colony,' Yeon Sang-ho's Cannes Midnight Screening thriller starring Gianna Jun.

Eli Lilly has agreed to pay up to $300 million for pre-clinical biotechnology company CrossBridge Bio in a deal that bolsters the drugmaker's cancer pipeline. The purchase price includes an ...

China-based company Xiamen Kang Zhongyuan Biotechnology Co., Ltd has issued a recall for multiple cough drop products, ...